+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas: An immunohistochemical and ultrastructural study



Angiogenesis spectrum in the stroma of B-cell non-Hodgkin's lymphomas: An immunohistochemical and ultrastructural study



European Journal of Haematology 56(1-2): 45-53



Samples of lymph nodes from 88 patients with B-cell non-Hodgkin's lymphoma (B-NHL) grouped by the Working Formulation (WF) and from 15 patients with benign lymphadenopathies were investigated immunohistochemically and ultrastructurally for changes in angiogenesis and stromal distribution of two subendothelial basement membrane (BM) components, namely laminin and type IV collagen. The microvessel number was usually low in lymphadenopathies, and increased significantly in low-grade B-NHL. Intermediate-grade tumors displayed a further significant increase that was mainly due to their diffuse subtypes rather than to the follicular subtype. High-grade B-NHL showed the highest counts. By contrast with the lymphadenopathies studied, the stroma of B-NHL reacted intensely with both BM components, whose linear co-expression was significantly associated with low-grade and follicular intermediate-grade B-NHL, while expression of laminin alone in a granular pattern was detected in diffuse intermediate-grade and high-grade tumors. Ultrastructural analysis revealed immature vessels more frequently in diffuse intermediate-grade, and in high-grade B-NHL. These in situ data suggest that angiogenesis occurring in B-NHL increases along their progression path, and emphasize the importance of angiogenesis as an epigenetic phenomenon of B-NHL progression.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008162048

Download citation: RISBibTeXText

PMID: 8599993

DOI: 10.1111/j.1600-0609.1996.tb00293.x


Related references

B-cell lymphomas (non-Hodgkin's lymphomas of B type) in children--morphologic and immunologic spectrum. Klinische Padiatrie 194(4): 226-232, 1982

Detection of bcl-2/JH gene rearrangements in non-Hodgkin's lymphomas and chronic tonsillitis, but not in Hodgkin's lymphomas. Molecular genetic and immunohistochemical study. Der Pathologe 14(6): 302-306, 1993

Amorphous matrices in pathology: their definition and place in the spectrum of morphological variations in the vessel-stroma interface. (Re: Lugassy et al., 1998. Angio-tumoral laminin in murine tumors derived from human melanoma cell lines. Immunohistochemical and ultrastructural observations. J. Submicrosc. Cytol. Pathol., 30, 231-237). Journal of Submicroscopic Cytology and Pathology 31(4): 585-587, 2000

Development of stroma in malignant lymphomas of the brain compared with epidural lymphomas. An immunohistochemical study. Acta Neuropathologica 71(1-2): 125-129, 1986

Do mast cells help to induce angiogenesis in B-cell non-Hodgkin's lymphomas?. British Journal of Cancer 77(11): 1900-1906, 1998

Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. International Journal of Cancer 85(2): 171-175, Jan 15, 2000

Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease. Blood 86(6): 2321-2328, 1995

Expression of tenascin is related to histologic malignancy and angiogenesis in b-cell non-Hodgkin's lymphomas. Leukemia and Lymphoma 22(5-6): 473-481, 1996

Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas. Journal of Pathology 202(1): 60-69, 2003

Mast cell heterogeneity in B-cell non-Hodgkin's lymphomas: an ultrastructural study. Leukemia and Lymphoma 43(11): 2201-2205, 2003

Immunohistochemical analysis of human MHC class II antigens in B-cell non-Hodgkin's lymphomas. Journal of Pathology 145(2): 185-194, 1985

B-cell non-Hodgkin lymphomas in Uganda: an immunohistochemical appraisal on tissue microarray. Human Pathology 39(6): 817-823, 2008

Filiform large-cell lymphomas. An ultrastructural and immunohistochemical study. American Journal of Surgical Pathology 11(5): 387-396, 1987

Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. British Journal of Cancer 79(5-6): 965-970, 1999

Angiogenesis induced by B-cell non-Hodgkin's lymphomas. Lack of correlation with tumor malignancy and immunologic phenotype. Anticancer Research 10(2a): 401-406, 1990